Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

NCT00462202 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

200

Enrollment

INDUSTRY

Sponsor class

Stopped Interim analysis of efficacy trial showed no drug efficacy.

Conditions

Diabetic Nephropathy

Interventions

DRUG: sulodexide

Sponsor

Keryx Biopharmaceuticals

Collaborators

[object Object]